Shanghai Model Organisms Center Inc (SHG:688265) — Market Cap & Net Worth
Market Cap & Net Worth: Shanghai Model Organisms Center Inc (688265)
Shanghai Model Organisms Center Inc (SHG:688265) has a market capitalization of $593.24 Million (CN¥4.05 Billion) as of September 24, 2026. Listed on the SHG stock exchange, this China-based company holds position #11533 globally and #3298 in its home market, demonstrating a 31.08% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shanghai Model Organisms Center Inc's stock price CN¥52.00 by its total outstanding shares 77963513 (77.96 Million). Also see Shanghai Model Organisms Center Inc balance sheet assets for a full breakdown of the balance sheet.
Shanghai Model Organisms Center Inc Market Cap History: 2021 to 2026
Shanghai Model Organisms Center Inc's market capitalization history from 2021 to 2026. Data shows change from $790.96 Million to $593.24 Million (-5.70% CAGR). Also see how efficiently does Shanghai Model Organisms Center Inc generate cash for how efficiently the company converts equity into cash flow.
Shanghai Model Organisms Center Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shanghai Model Organisms Center Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check today's stock price for Shanghai Model Organisms Center Inc for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
1.11x
Shanghai Model Organisms Center Inc's market cap is 1.11 times its annual revenue
Latest Price to Earnings (P/E) Ratio
14.43x
Shanghai Model Organisms Center Inc's market cap is 14.43 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $790.96 Million | $275.27 Million | $60.86 Million | 2.87x | 13.00x |
| 2022 | $555.54 Million | $302.97 Million | -$5.40 Million | 1.83x | N/A |
| 2023 | $435.93 Million | $366.55 Million | -$20.58 Million | 1.19x | N/A |
| 2024 | $263.76 Million | $381.24 Million | $6.50 Million | 0.69x | 40.61x |
| 2025 | $467.86 Million | $421.26 Million | $32.43 Million | 1.11x | 14.43x |
Competitor Companies of 688265 by Market Capitalization
Companies near Shanghai Model Organisms Center Inc in the global market cap rankings as of September 24, 2026. Review 688265 tangible net assets ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Shanghai Model Organisms Center Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #187 globally with a market cap of $130.53 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #334 globally with a market cap of $80.46 Billion USD.
- CSL Ltd (AU:CSL): Ranked #451 globally with a market cap of $62.04 Billion USD ( AU$87.68 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #510 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #187 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.53 Billion | $514.99 |
| #334 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $80.46 Billion | $803.90 |
| #451 | CSL Ltd | AU:CSL | $62.04 Billion | AU$180.72 |
| #510 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $182.56 |
Shanghai Model Organisms Center Inc Historical Marketcap From 2021 to 2026
Between 2021 and today, Shanghai Model Organisms Center Inc's market cap moved from $790.96 Million to $ 593.24 Million, with a yearly change of -5.70%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥593.24 Million | +26.80% |
| 2025 | CN¥467.86 Million | +77.38% |
| 2024 | CN¥263.76 Million | -39.49% |
| 2023 | CN¥435.93 Million | -21.53% |
| 2022 | CN¥555.54 Million | -29.76% |
| 2021 | CN¥790.96 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 23rd, 2026 the market cap of Shanghai Model Organisms Center Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $593.24 Million USD |
| MoneyControl | $593.24 Million USD |
| MarketWatch | $593.24 Million USD |
| marketcap.company | $593.24 Million USD |
| Reuters | $593.24 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Shanghai Model Organisms Center Inc
Shanghai Model Organisms Center, Inc. engages research and development, production, sale, and related technical services of genetically modified animal models. It uses model organisms, such as mice, rats, zebrafish, and nematodes as carriers which uses gene editing technology to introduce or delete target DNA fragments. The company offers toolbox of mice; disease mice, such as rare, infectious, a… Read more